A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer.
Saved in:
| Title: | A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer. |
|---|---|
| Authors: | Duan, Hongtao1 (AUTHOR), Wang, Zhaoyang1 (AUTHOR), Cao, Lili2 (AUTHOR), Zhu, Yifang1 (AUTHOR) zyfdht321@sina.com, Tong, Liping1 (AUTHOR) 281071642@qq.com, Yan, Xiaolong1 (AUTHOR) yanxiaolong@fmmu.edu.cn |
| Source: | Thoracic Cancer. Jul2024, Vol. 15 Issue 19, p1471-1476. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 178211247 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Duan%2C+Hongtao%22">Duan, Hongtao</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhaoyang%22">Wang, Zhaoyang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Lili%22">Cao, Lili</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Yifang%22">Zhu, Yifang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> zyfdht321@sina.com</i><br /><searchLink fieldCode="AR" term="%22Tong%2C+Liping%22">Tong, Liping</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> 281071642@qq.com</i><br /><searchLink fieldCode="AR" term="%22Yan%2C+Xiaolong%22">Yan, Xiaolong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> yanxiaolong@fmmu.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Thoracic+Cancer%22">Thoracic Cancer</searchLink>. Jul2024, Vol. 15 Issue 19, p1471-1476. 6p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=178211247 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/1759-7714.15312 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 1471 Titles: – TitleFull: A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Duan, Hongtao – PersonEntity: Name: NameFull: Wang, Zhaoyang – PersonEntity: Name: NameFull: Cao, Lili – PersonEntity: Name: NameFull: Zhu, Yifang – PersonEntity: Name: NameFull: Tong, Liping – PersonEntity: Name: NameFull: Yan, Xiaolong IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 17597706 Numbering: – Type: volume Value: 15 – Type: issue Value: 19 Titles: – TitleFull: Thoracic Cancer Type: main |
| ResultId | 1 |